Clinical trial suggests convalescent plasma may improve survival with severe COVID-19

ScienceDaily
May 17, 2021, 12:50 pm112 pts
A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate seen in the control arm (12.6 percent vs. 24.6 percent), although treatment was not associated with other improvements in clinical…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

By 2051, emissions from coal mining on federal lands could drop by 86% 128

15 Children in Wisconsin File the Latest Youth Lawsuit Citing Climate Dangers 126

Hyundai Motor Brings Retro Arcade Fun With INSTEROID Concept Car to gamescom 2025 121

Breaking Rules but Not Waves: Plasmons in Correlated Materials 119

China Flexes Its Green Hydrogen Muscles In Europe 115

Climate Change Brings More Rapidly Intensifying Hurricanes; NOAA Cuts Make Forecasting Them Harder 113

'We must tackle common challenges together' 111

Navigating the Troubled Waters of Newton Creek Means an Environmental Cleanup in Brooklyn and Queens That Will Cost At Least $3.3 Billion 107

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.